4.2.3.5	(17beta)-17-(4-hydroxybenzoyl)androsta-3,5-diene-3-carboxylic acid	-	226139	
4.2.3.5	(2E)-5,7-dihydroxy-2-[[4-(pyrrolidin-1-yl)phenyl]methylidene]-1-benzofuran-3(2H)-one	-	228174	
4.2.3.5	(2E)-5,7-dihydroxy-2-[[4-(trifluoromethyl)phenyl]methylidene]-1-benzofuran-3(2H)-one	-	228173	
4.2.3.5	(2E)-6,7-dihydroxy-2-([2-hydroxy-4-[(6-hydroxyhexyl)oxy]phenyl]methylidene)-1-benzofuran-3(2H)-one	-	228175	
4.2.3.5	(3R,4R,5R)-5-(carboxymethoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85392	
4.2.3.5	(3R,4S,5R)-4-hydroxy-3-[(2S)-1-hydroxy-1-oxo-2-phosphonooxypropan-2-yl]oxy-5-phosphonooxycyclohexene-1-carboxylic acid	-	85393	
4.2.3.5	(3R,4S,5R)-5-(1-carboxyethoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85394	
4.2.3.5	(3R,4S,5R)-5-[(1R)-1-carboxy-1-phosphonoethoxy]-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85396	
4.2.3.5	(3R,4S,5S,6S)-5-(1-carboxyethenoxy)-6-fluoro-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85395	
4.2.3.5	(6R)-6-fluoro-5-enoylpyruvylshikimate 3-phosphate	IC50 is 0.0005 mM when the enzyme is preincubated with the inhibitor, the IC50 is 0.25 mM when the enzyme is not preincubated with the inhibitor, inhibition is not absolutely irreversible	54530	
4.2.3.5	(6S)-6-fluoro-5-enolpyruvylshikimate 3-phosphate	competitive inhibitor	66812	
4.2.3.5	([1,1'-biphenyl]-4-yl)(4-nitrophenyl)methanone	-	226153	
4.2.3.5	1-(naphthalen-2-yl)-2-[(6-nitro-1,3-benzothiazol-2-yl)sulfanyl]ethan-1-one	-	226147	
4.2.3.5	2-difluoro-[1-phosphonooxyethoxy]-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85397	
4.2.3.5	3,4-di(1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	-	226141	
4.2.3.5	4-[(E)-(5,7-dihydroxy-3-oxo-1-benzofuran-2(3H)-ylidene)methyl]benzoic acid	-	226149	
4.2.3.5	4-[7-(hydroxymethyl)-1-benzofuran-2-yl]-7-methyl-2-oxo-2H-1-benzopyran-6-yl furan-2-carboxylate	-	226152	
4.2.3.5	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	-	226145	
4.2.3.5	6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid	-	226146	
4.2.3.5	bathophenanthroline	-	2722	
4.2.3.5	CHEMBL135212	-	228166	
4.2.3.5	CHEMBL335859	-	228168	
4.2.3.5	CHEMBL336282	-	228169	
4.2.3.5	CHEMBL338732	-	228167	
4.2.3.5	diethyl dicarbonate	-	463	
4.2.3.5	dioxygen	inactivation	32877	
4.2.3.5	Fe2+	-	25	
4.2.3.5	N-(2-benzoyl-3-methyl-1-benzofuran-6-yl)-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butanamide	-	226144	
4.2.3.5	N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide	-	226142	
4.2.3.5	N-[2-(4-methoxybenzoyl)-3-methyl-1-benzofuran-5-yl]-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)acetamide	-	226143	
4.2.3.5	N-[5-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)-1H-indazol-3-yl]-2-[4-(piperidin-1-yl)phenyl]acetamide	-	226140	
4.2.3.5	O2	activity only in anaerobic conditions	9	
4.2.3.5	ZINC00602427	-	228163	
4.2.3.5	ZINC01163259	-	228165	
4.2.3.5	ZINC01587011	-	228164	
4.2.3.5	ZINC03803450	-	228159	
4.2.3.5	ZINC09708077	-	228172	
4.2.3.5	ZINC13387711	-	228161	
4.2.3.5	ZINC13681793	-	228171	
4.2.3.5	ZINC13682976	-	228170	
4.2.3.5	ZINC16052528	-	228162	
4.2.3.5	ZINC20149031	-	228160